NEW YORK, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)HEREDITARY DISEASE FOUNDATION, founded in 1968, is a community nonprofit in the Medical Research sector that reported $7.9M in total revenue in fiscal year 2024. Revenue surged 206% from the prior year, signaling strong growth momentum. The organization ran a surplus of $3.4M, a strong 43% operating margin.
TO FUND TRANSFORMATIVE RESEARCH TO FIND TREATMENTS, AND ULTIMATELY A CURE, FOR HUNTINGTON'S DISEASE.
THE HEREDITARY DISEASE FOUNDATION (HDF) ADVANCES PARADIGM-CHANGING HUNTINGTON'S DISEASE (HD) RESEARCH THROUGH A COLLABORATIVE APPROACH TO SCIENTIFIC DISCOVERY. WE INVEST IN RESEARCH BY PROVIDING...
THE HEREDITARY DISEASE FOUNDATION (HDF) ADVANCES PARADIGM-CHANGING HUNTINGTON'S DISEASE (HD) RESEARCH THROUGH A COLLABORATIVE APPROACH TO SCIENTIFIC DISCOVERY. WE INVEST IN RESEARCH BY PROVIDING SENIOR SCIENTISTS WITH GRANTS, INCLUDING OUR MILLION-DOLLAR TRANSFORMATIVE RESEARCH AWARDS, WHICH BEGAN IN 2023, AND FUNDING THE WORK OF EARLY CAREER SCIENTISTS THROUGH POSTDOCTORAL FELLOWSHIPS. WE CHAMPION COLLABORATIVE SCIENCE BY ORGANIZING BOTH SMALL THINKTANK-STYLE WORKSHOPS AND LARGE SCIENTIFIC CONFERENCES WHICH ENABLE EXPERTS IN HD TO SHARE THEIR LATEST DISCOVERIES, EXPLORE CUTTING-EDGE TECHNOLOGIES, AND FORM COLLABORATIONS. WE HIGHLIGHT FOR THE PUBLIC NOTABLE WORK OF SCIENTISTS THROUGH OUR WEBINARS.(CONTINUED ON SCHEDULE O)IN ITS EARLY YEARS, RESEARCH ORGANIZED AND FUNDED BY THE HDF WAS THE CATALYST FOR THE WORK THAT ISOLATED THE GENE THAT CAUSES HUNTINGTON'S DISEASE. THIS FINDING LED TO THE DEVELOPMENT OF A GENETIC TEST FOR HD AND LAUNCHED MODERN RESEARCH EFFORTS. THE HEREDITARY DISEASE FOUNDATION SUPPORTS RESEARCH THROUGH SEVERAL FUNDING OPPORTUNITIES.HDF RESEARCH GRANTS: ONE-YEAR GRANTS PROVIDE SENIOR RESEARCHERS WITH SEED FUNDING TO ENABLE THEM TO COLLECT THE PRELIMINARY DATA NEEDED TO OBTAIN MAJOR, LONG-TERM FUNDING FROM OTHER ORGANIZATIONS, INCLUDING THE NIH.HDF POSTDOCTORAL FELLOWSHIPS: TWO-YEAR FELLOWSHIPS FUND THE WORK OF EARLY-CAREER SCIENTISTS. THESE FELLOWSHIPS ARE INTENDED TO ENCOURAGE AND CULTIVATE INTEREST IN HUNTINGTON'S DISEASE RESEARCH.TRANSFORMATIVE RESEARCH AWARDS: THESE MILLION-DOLLAR RESEARCH AWARDS, HDF'S LARGEST GRANTS, FUND COLLABORATIVE RESEARCH TEAMS TO CREATE INNOVATIVE WAYS TO STUDY NEW PATHOGENIC DISEASE MECHANISMS AND TREATMENT MODALITIES IN HUNTINGTON'S DISEASE.HD CAREER ADVANCEMENT GRANTS: THESE ARE OUR NEWEST AWARDS WITH GRANTS BEGINNING IN 2025. THIS INCUBATOR PROGRAM SUPPORTS YOUNG INVESTIGATORS BY PROVIDING RESOURCES AND TOOLS TO BUILD THE NECESSARY SKILLS TO BRIDGE THE TRANSITION FROM POSTDOCTORAL POSITION TO TENURE-TRACK PRIMARY INVESTIGATOR. OUR GOAL THROUGH THIS PROGRAM AND OUR POSTDOCTORAL FELLOWSHIPS IS TO ENGAGE AND RETAIN THE BRIGHTEST MINDS IN HD RESEARCH BY FUNDING AND MENTORING EARLY-CAREER SCIENTISTS.HDF-FUNDED RESEARCHERS HAVE MADE SIGNIFICANT STRIDES IN APPLYING ADVANCED TECHNIQUES SUCH AS ARTIFICIAL INTELLIGENCE (AI), CRISPR AND BRAIN MAPPING, LEADING TO TREMENDOUS PROMISE FOR POTENTIAL TREATMENTS FOR HUNTINGTON'S DISEASE.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $7,899,221 | $2,578,841 | +2.1% |
| Expenses | $4,524,145 | $4,738,635 | 0.0% |
| Net Income | $3,375,076 | $-2,159,794 | -2.6% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| MEGHAN DONALDSON | CEO | 40.00 |
Officer
Director
|
$110,000 | $0 | $110,000 |
| KAREN NEWMAN | CHAIR | 24.00 |
Officer
Director
|
$12,000 | $0 | $12,000 |
| NANCY S WEXLER PHD | PRESIDENT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| ANNE B YOUNG MD PHD | VICE CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| BRUCE DONALDSON | TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| ALICE WEXLER PHD | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| C FRANK BENNETT PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ROBI BLUMENSTEIN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| SANDY FOX | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| TACIE FOX | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| BERTA A GEHRY | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| FRANK O GEHRY | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| DAVID HOUSMAN PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JOAN LEIMAN PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| HERBERT PARDES MD | DIRECTOR (THROUGH 4/24) | 1.00 |
Director
|
$0 | $0 | $0 |
| LAUREN BAKER PINKUS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| LESLIE M THOMPSON PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| DAVID ZWALLY | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MELISSA MOSER | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| TIM KELLEHER | CFO | 6.00 |
Officer
|
$42,765 | $0 | $42,765 |
| SARAH HERNANDEZ | DIR. OF RESEARCH PROGRAMS | 40.00 |
Highest
|
$143,929 | $55,917 | $199,846 |
| JULIE PORTER | DIR. OF ADMINISTRATION | 40.00 |
Highest
|
$116,065 | $30,005 | $146,070 |
| ERICA MATISZ | DIR. OF DEVELOPMENT | 40.00 |
Highest
|
$108,500 | $0 | $108,500 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | $7,899,221 | $4,524,145 | $21,978,294 | $3,375,076 |
| 2023 | $2,578,841 | $4,738,635 | $18,234,308 | $-2,159,794 |
| 2022 | $4,522,686 | $2,603,305 | $16,776,193 | $1,919,381 |
| 2021 | $3,846,649 | $2,967,624 | $18,145,612 | $879,025 |
| 2020 | $4,059,819 | $2,519,661 | $15,507,063 | $1,540,158 |
| 2019 | $2,027,985 | $2,301,831 | $12,457,716 | $-273,846 |
| 2018 | $2,691,357 | $2,137,659 | $10,922,906 | $553,698 |
Compare HEREDITARY DISEASE FOUNDATION with other nonprofits in New York and across the country.